Guangzhou Red Pine Medical Instrument Co., Ltd., a leading company in the disposable endoscope sector, has reportedly secured “hundreds of millions” of renminbi in a Series D financing round. The round was led by CICC Capital, with significant contributions from Guangzhou Industrial Investment and Capital, Oriza Seed, and other investors. The funds raised will be directed towards product iteration and the strategic development of the company’s overseas business.- Flcube.com
Recent news:
-
Sino Biopharmaceutical Submits NDA for Anlotinib and Penpulimab Combo in HCC to NMPA -
Sihuan Pharmaceutical's Huisheng Pharm Strikes Exclusive Deal for Semaglutide Biosimilar in China -
Innovent Biologics' IBI354 Earns Breakthrough Therapy Designation for Ovarian Cancer Treatment -
CDE Includes Double-Crane's Hydroxocobalamine and Sanofi Genzyme's Fitusiran in Rare Disease Care Plan -
Apeiron Therapeutics Initiates Phase Ia/B Study for GTA182 in Solid Tumors with MTAP Deficiency
